XBIT - NASDAQ

XBiotech Inc.

XBIT·NASDAQ

$2.37

-1.2%

HealthcareBiotechnology

XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and inflammation, and True Human COVID-19 therapy for treating the COVID-19 mutant virus. The company was incorporated in 2005 and is headquartered in Austin, Texas.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$72.26M

EPS-1.4900

P/E Ratio-1.59

Earnings Date05/14/2026

xbit

Accrued Expenses

Last Annual Value

0.00

3-Year CAGR

5-Year CAGR

10-Year CAGR

Adjust for Inflation

XBiotech Inc. Competitors Analysis of Accrued Expenses

XBIT · NASDAQ

Company	Accrued Expenses	CAGR 3Y	CAGR 5Y	CAGR 10Y
XBiotech Inc. NASDAQ:XBIT	0.00	N/A	N/A	N/A
Clene Inc. NASDAQ:CLNN	0.00	N/A	N/A	N/A
MindWalk Holdings Corp. NASDAQ:HYFT	0.00	N/A	N/A	N/A
Immix Biopharma, Inc. NASDAQ:IMMX	0.00	N/A	N/A	N/A
PMV Pharmaceuticals, Inc. NASDAQ:PMVP	0.00	N/A	N/A	N/A
Vaxart, Inc. NASDAQ:VXRT	0.00	N/A	N/A	N/A
Lite Strategy, Inc. NASDAQ:LITS	873.00K	-45.1%	-24.3%	N/A
Nutriband Inc. NASDAQ:NTRB	0.00	N/A	N/A	N/A
Relmada Therapeutics, Inc. NASDAQ:RLMD	0.00	N/A	N/A	N/A
CervoMed Inc. NASDAQ:CRVO	1.41M	26.4%	-6.0%	13.4%
Fortress Biotech, Inc. NASDAQ:FBIO	28.91M	50.2%	26.8%	4.5%

XBiotech Inc. Fair Value Envelope

XBIT · NASDAQ

Our analysis suggests that XBIT has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $2.37, this represents a potential HIDDEN relative to our calculated worth for XBiotech Inc..

HIDDEN

Intrinsic Value

Current Price: $2.37

Related Guides

Blog Categories

Continue your XBIT research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.